Patent · US Expired

Antibodies to .beta.-amyloids or their derivatives and use thereof

US5750349A · kind A · utility

167Cited by
0References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 15, 1994
Grant dateMay 12, 1998
Priority date
Expiry dateSep 15, 2014

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

According to this invention, antibodies which are useful and novel in that they have binding specificity to .beta.-amyloids or derivatives thereof, namely recognize the N-terminal, the C-terminal or central portions of the .beta.-amyloids, respectively, were obtained. By combining these antibodies, determination methods by which the .beta.-amyloids could be determined sensitively and specifically are provided. These determination methods are useful for diagnosis of diseases to which the .beta.-amyloids or their derivatives are related (for example, Alzheimer's disease), and the antibodies of this invention are useful for the development of preventive-therapeutic compositions for Alzheimer's disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.